Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt
- Sponsor
- Assiut University
- Study ID
- NCT07495644
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab — BIOLOGICALEfficacy of different biological treatment on patient with inflammatory bowel disease
Study Details
To study the efficacy of different biological treatment on patient with inflammatory bowel disease after one year of treatment in upper egypt
Key Dates
- Start date
- Mar 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Mar 31, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 95 participants (estimated)
Primary Outcome Measure
Efficacy of different biological treatment on patient with inflammatory bowel disease after one year of treatment in upper egypt [ Time Frame: 1 year ]
Central Contacts
- Mary George Benyamin Tanious, Resident physician+20 1555227403
- Mohamed Abd Elhakim omran, Assistant literature+20 1067663269